Peptide-powered wellness.
Direct-pay telehealth, 48 states + DC.
Microdose GLP-1
Physician-supervised evaluation for adults whose physician may determine a lower-dose, slower-titration plan is clinically appropriate. Treatment decisions are individualized by the prescribing physician.
Scaffold — pending content approval
This hub page's metadata, FAQ structure, and JSON-LD are live. The full 1,500–2,000 word body is awaiting your sign-off on the proposed metadata and section outline (see comment block at the top of page.tsx). Once you approve, we'll replace this notice with the full body, internal links, and citations.
Microdosing GLP-1 is a low-dose, physician-supervised approach to using semaglutide or tirzepatide for body recomposition rather than significant weight loss. The protocol uses doses well below the trial-dose escalation curve and adjusts based on composition signals, not scale change.
For patients pursuing recomposition, the goal is a sustainable appetite signal without the gastrointestinal disruption associated with standard-dose escalation. Eligibility is determined individually by a licensed physician.
Compare
Full-dose escalation for significant weight loss — see the standard protocol.
Compare
Dual-receptor protocol for the most clinically intensive weight-loss track.
Sibling hub
Peptide stacks paired with microdose GLP-1 — the full recomposition protocol.
Read more
Plain-language posts on dosing, candidacy, and timeline.
FAQ
Microdosing GLP-1 means using a low weekly dose of a GLP-1 receptor agonist (semaglutide or tirzepatide) to nudge appetite signaling without producing the strong appetite suppression and gastrointestinal side effects associated with the standard escalation curve. The dose is typically a fraction of the doses used in the published weight-loss trials, and the cadence is calibrated by a physician to the individual patient.
Standard GLP-1 protocols escalate weekly doses over several months toward a target dose designed to produce significant weight loss. Microdose protocols start lower and stay lower — the goal is sustainable composition change, not rapid scale change. Day-to-day, microdose patients typically describe a quieter appetite signal and less gastrointestinal disruption than patients on the standard escalation curve.
Whether a lower-dose plan is clinically appropriate is determined individually by your prescribing physician based on medical history, BMI, comorbidities, and treatment goals. TelePeptide does not promote this protocol for bodybuilding, athletic performance, aesthetic purposes, or as a generic substitute for an FDA-approved branded medication.
Patients whose clinical picture calls for significant weight loss are typically better served by standard-dose protocols, where the dose-response data is much stronger. Microdosing is not appropriate for patients with certain thyroid conditions, pancreatitis history, or other contraindications. A physician will make this call during intake based on goals, history, and labs.
Because the goal is composition rather than scale, the monitoring cadence emphasizes things the scale does not capture — waist circumference, training session quality, and patient-reported energy and recovery. The scale is still tracked, but it is not the primary signal. Individual results vary, and TelePeptide does not promise any specific outcome.
Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of branded medications, and are not represented as therapeutically equivalent to any FDA-approved product. They are prepared by licensed 503A or 503B compounding pharmacies under specific federal rules. Whether a compounded preparation is appropriate for a given patient is an individualized clinical decision made by the prescribing physician.
Microdose GLP-1 protocols are priced the same as the standard-dose program. The physician determines the dose, not the price tier. Founder-rate pricing is locked in.
Complete the online intake. A licensed physician will review your goals, training history, and medical context within 48 hours and recommend a microdose, standard-dose, or alternative protocol — or determine you are not a candidate.
Next Step
A licensed physician will review your goals and recommend the right protocol — peptide wellness, recomposition, or supervised weight loss. No insurance, no waiting room.
Compounded medications are prepared by licensed 503A pharmacies. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA. Compounded medications are not FDA-approved.